SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-14-003582
Filing Date
2014-04-09
Accepted
2014-04-09 09:01:45
Documents
3
Period of Report
2014-05-28
Effectiveness Date
2014-04-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2219467zdef14a.htm DEF 14A 526226
2 G24982BCI001.GIF g24982bci001.gif GRAPHIC 52286
3 G24982BCI002.GIF g24982bci002.gif GRAPHIC 35980
  Complete submission text file 0001047469-14-003582.txt   649366
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 14752536
SIC: 2835 In Vitro & In Vivo Diagnostic Substances